# Safety and Performance Evaluation of a New Catheter Range for Lead Implantation at Interventricular Septum

Study · id `cardio:ct-nct06453850` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06453850](<https://clinicaltrials.gov/study/NCT06453850>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06453850

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 216 participants.

## Technical summary

Registry record NCT06453850. Allocation not applicable; no masking; primary purpose treatment. Start 2025-02-14 (actual); primary completion 2025-06-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 216 participants (enrolled count; ClinicalTrials.gov record NCT06453850, source copy `cardio:ctgov-nct06453850-2026-09-23`, retrieved 2026-10-26)
- Started: 2025-02-14 (actual) (ClinicalTrials.gov record NCT06453850, source copy `cardio:ctgov-nct06453850-2026-09-23`, retrieved 2026-10-26)
- Primary completion: 2025-06-06 (actual) (ClinicalTrials.gov record NCT06453850, source copy `cardio:ctgov-nct06453850-2026-09-23`, retrieved 2026-10-26)
- Completion: 2026-04-30 (actual) (ClinicalTrials.gov record NCT06453850, source copy `cardio:ctgov-nct06453850-2026-09-23`, retrieved 2026-10-26)
- Countries: France; Germany; Italy; Portugal; Spain (ClinicalTrials.gov record NCT06453850, source copy `cardio:ctgov-nct06453850-2026-09-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06453850-2026-09-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Performance Evaluation of a New Catheter Range for Lead Implantation at Interventricular Septum
- Acronym: POLARIS
- Condition: Bradycardia
- Condition: Cardiac Resynchronization Therapy
- Condition: Left Bundle Branch Area Pacing
- Condition: Left Bundle Branch Pacing
- Intervention (Device): Use of FLEXIGO delivery catheter
- Lead sponsor: MicroPort CRM
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Bradycardia (`cardio:bradycardia`)
- Registry lists this organization as the lead sponsor: MicroPort CRM (`cardio:org-microport-crm`)

## Provenance

Content hash: b04635cb6f6b27e1a5b47d3026483d715beb359e81f1d015ef83e015608453e7
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
